(Q36350671)

13 August 2017

Antitumor activity of recombinant interleukin 6 in mice (English)

1 reference

13 August 2017

Mulé JJ

1

1 reference

13 August 2017

McIntosh JK

series ordinal

2

1 reference

13 August 2017

Jablons DM

series ordinal

3

1 reference

13 August 2017

Rosenberg SA

series ordinal

4

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 March 1990

1 reference

Journal of Experimental Medicine

13 August 2017

1 reference

13 August 2017

171

1 reference

13 August 2017

629-636

1 reference

13 August 2017

3

1 reference

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187775

B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187775

Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187775

Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6)

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187775

Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gamma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187775

Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187775

Serologic Identification of Multiple Tumor-Associated Antigens on Murine Sarcomas

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187775

Purification and physico-chemical characterization of rabbit tumor necrosis factor.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187775

Production of hybridoma growth factor by human monocytes.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187775

Eradication of disseminated murine leukemia by treatment with high-dose interleukin 2

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187775

Multiple actions of interleukin 6 within a cytokine network

21 October 2018

1 reference

12 December 2020

Human beta 2 interferon and B-cell differentiation factor BSF-2 are identical

1 reference

12 December 2020

Purification and NH2-terminal sequence of a plasmacytoma growth factor derived from the murine macrophage cell line P388D1

1 reference

12 December 2020

Biological Activity of Recombinant Human Interleukin-2 Produced inEscherichia coli

1 reference

12 December 2020

Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2

1 reference

12 December 2020

Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (RIL 2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinoma

1 reference

12 December 2020

Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2

1 reference

12 December 2020

Synergistic antitumor effects of immunotherapy with recombinant interleukin-2 and recombinant tumor necrosis factor-alpha

1 reference

12 December 2020

IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans

1 reference

12 December 2020

In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice

1 reference

12 December 2020

Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas

1 reference

12 December 2020

Characterization of a novel murine T cell-activating factor

1 reference

12 December 2020

Identifiers

DOI

10.1084/JEM.171.3.629

1 reference

release_7oarnpgii5evnor4imndwf72ri

13 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7oarnpgii5evnor4imndwf72ri

24 November 2022

mapped directly with Wikidata item

1 reference

13 August 2017

1 reference